Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) has been given an average recommendation of “Moderate Buy” by the twelve brokerages that are covering the company, MarketBeat Ratings reports. Six research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $61.18.
A number of equities research analysts have commented on TEM shares. JPMorgan Chase & Co. cut Tempus AI from an “overweight” rating to a “neutral” rating and increased their price target for the company from $50.00 to $55.00 in a research note on Tuesday, February 25th. Bank of America increased their price objective on shares of Tempus AI from $54.00 to $60.00 and gave the company a “neutral” rating in a research report on Monday, March 3rd. Needham & Company LLC boosted their target price on shares of Tempus AI from $56.00 to $70.00 and gave the stock a “buy” rating in a research report on Tuesday, February 25th. TD Cowen reaffirmed a “buy” rating and issued a $74.00 price target (up previously from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th. Finally, Loop Capital lowered their price objective on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a research note on Tuesday, January 14th.
Get Our Latest Report on Tempus AI
Insider Buying and Selling at Tempus AI
Institutional Investors Weigh In On Tempus AI
Several hedge funds have recently modified their holdings of the company. ARK Investment Management LLC increased its stake in shares of Tempus AI by 132.1% in the 4th quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company’s stock valued at $186,343,000 after purchasing an additional 3,141,487 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. grew its holdings in Tempus AI by 166.0% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company’s stock valued at $109,352,000 after purchasing an additional 2,021,394 shares during the period. Nikko Asset Management Americas Inc. increased its position in shares of Tempus AI by 166.0% in the fourth quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company’s stock valued at $109,352,000 after buying an additional 2,021,394 shares in the last quarter. Franklin Resources Inc. raised its stake in shares of Tempus AI by 240.5% during the 4th quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company’s stock worth $93,251,000 after buying an additional 1,950,862 shares during the period. Finally, JPMorgan Chase & Co. lifted its position in shares of Tempus AI by 86,947.2% during the 4th quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company’s stock valued at $55,836,000 after buying an additional 1,651,996 shares in the last quarter. 24.22% of the stock is owned by hedge funds and other institutional investors.
Tempus AI Trading Up 0.0 %
Shares of TEM opened at $48.04 on Friday. Tempus AI has a 12 month low of $22.89 and a 12 month high of $91.45. The stock has a fifty day moving average price of $56.07 and a 200-day moving average price of $51.45. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17.
Tempus AI Company Profile
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Recommended Stories
- Five stocks we like better than Tempus AI
- How to Profit From Growth Investing
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Top Stocks Investing in 5G Technology
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.